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Conclusions: The Global Diffusion of Casemix
Abstract
The previous chapters have presented summaries of the adoption of patient classification systems (PCS)
in fifteen countries around the globe, starting with the US in 1983 and continuing through to Germany in
2005. The purpose of this final chapter is to stand back from the details of each country's experience with
patient classification systems and analyze patterns of convergence and divergence in these experiences.
The chapters describe some similarities, but also a great deal of variation in the definition, goals, and
purposes of PCS from one country to the next as well as in the processes by which these systems were
adopted. These differences lead us to ask the following questions:
Why do some nations use PCS extensively, including, for example, as a payment method for health care
providers, while others rely relatively little on these systems?
What accounts for variation in the difficulty and duration of adoption and implementation of PCS across
nations?
What accounts for variation in the timing of adoption?Why have some nations just begun to use PCS,
while others have used them for more than twenty years?
Addressing these and related questions is important because the adoption and implementation of these
systems remains incomplete both within and across nations. There may well be key lessons to be learned
from examining adoption patterns, and these lessons can inform decision makers who are both current
and potential users of this technology.
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Conclusions: The global diffusion of
casemix
Thomas D’Aunno, John R. Kimberly, and
Gérard de Pouvourville

Introduction
The previous chapters have presented summaries of the adoption of patient
classification systems (PCS) in fifteen countries around the globe, starting
with the US in 1983 and continuing through to Germany in 2005. The
purpose of this final chapter is to stand back from the details of each
country’s experience with patient classification systems and analyze patterns
of convergence and divergence in these experiences. The chapters describe
some similarities, but also a great deal of variation in the definition, goals,
and purposes of PCS from one country to the next as well as in the processes
by which these systems were adopted. These differences lead us to ask the
following questions:
 Why do some nations use PCS extensively, including, for example, as a
payment method for health care providers, while others rely relatively
little on these systems?
 What accounts for variation in the difficulty and duration of adoption
and implementation of PCS across nations?
 What accounts for variation in the timing of adoption? Why have some
nations just begun to use PCS, while others have used them for more
than twenty years?
Addressing these and related questions is important because the adoption
and implementation of these systems remains incomplete both within and
across nations. There may well be key lessons to be learned from examining
adoption patterns, and these lessons can inform decision makers who are
both current and potential users of this technology.
Similarly, health care systems around the world are now experimenting,
or soon will be, with many new management technologies, aiming to
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improve system effectiveness and efficiency. Comparing the experiences of
various countries with PCS may yield knowledge about what factors promote or inhibit the adoption of new management technologies in the health
sector. Finally, we believe that understanding the adoption of a new management technology in a complex and turbulent setting, such as the health
sector, can serve as a basis for understanding of the diffusion of management innovations more generally.
Of course, a large amount of literature on the adoption and diffusion of
management innovations (e.g. Rogers 2003; Guler, Guillen and MacPherson
2002) already exists as does an earlier book on the diffusion of Diagnostic
Related Groups (DRGs), the first PCS, from the US to Western Europe
(Kimberly and de Pouvourville 1993). The account we develop below draws
on this literature. We consider sociological, economic, political, and social–
psychological factors that may account for the variation we observe in PCS
adoption.
The chapter is divided into four sections. First, we discuss PCS as an
innovation: what are its distinctive features and how might these affect its
migration around the world? Second, we examine the variation in the
adoption of PCS across nations (see Table 16.1 below), focusing on key
dimensions of adoption, such as timing (early vs. late adopters); extent of
PCS use (e.g. is PCS used for outpatient or only inpatient services?); difficulty and duration of adoption process (how long did adoption take?);
differences in the uses of the systems; and differences in the origin of
national PCS (primarily home-grown vs. primarily adopted from external
sources). Third, we develop an analytic framework to account for PCS
diffusion drawing on a range of relevant literature. And finally, the chapter
concludes with a discussion of implications for policy makers, managers,
and researchers in the health sector and other sectors as well.

Characteristics of PCS as an innovation
The social aspects of PCS
We begin by arguing that PCS, like all innovations, has both social and
technical aspects (Callon 1987 and Latour 1987). Further, we argue that PCS
is primarily a managerial, rather than a purely technical innovation and, as
such, its social characteristics matter more for its use than its technical

Cambridge Books Online © Cambridge University Press, 2010

Table 16.1 Variation in patient classification system adoption

Country

Year of adoption

Origin of system

Goals and purpose of
the system

Australia

Exposure since 1981;
1993

Based on US model and
adapted to Australian
clinical practice data

Allocation of public
hospital budgets; cost
efficiency

Belgium

1990
Implementation
of ICD–9–CM coding
1995 adopted APR DRG

US model translated into Financial comparisons;
French and Flemish
control of length of
stay

Canada

1983
ICD–9–CM codes
Late 1980s Canadianspecific version
developed
1993 Day Procedure
Groupings
Late 1980s–early 1990s
Pilot studies
1994 White Paper using
NORD DRGs
2002 DkDRG
implemented

Adjustment of US DRG
system

Denmark

Difficulty and duration
of adoption and
implementation
Easy 5 months in State
of Victoria; 2-year
period staged
implementation;
casemix community
Difficult
Opposition from
physicians

Utilization management Easy
and financial, LOS
No delays or strong
comparisons; financial
opposition
comparability of
hospitals

Based on NORD DRGs, Productivity analysis of
Danish-specific version
hospitals; financing;
developed
consumer free choice
across country

Moderate
System not used
nationwide
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Extent of system use
Inpatient hospital care,
outpatient and
emergency care

Inpatient hospital care;
experiments/research
projects with ER,
nursing, psychiatric,
ICU, geriatrics,
rehabilitation and
dependency services
Inpatient, day surgery,
ER, ambulatory care,
home care, psychiatric
care, functional abilities

All hospital activity

France

Germany

Hungary

Italy

US Yale systems, with
1982–1989
adaptation and
US DRG research
refinements
projects
1986 French DRG
project–French grouper
based on HCFA 1985
DRG system
1994 Implemented
1996 Full data
1998 Productivity report
available
1997–1998 Discharge data
recorded
2005
Australian DRG system;
DRGs introduced in
Australian procedure
phases, beginning
code mapped to
in 2002; much
German code
preparation work
completed earlier

Financing hospitals
(recent goal)

Difficult
Acute hospital care
Conflicting policy,
(medical, surgical and
different payment rules
obstetrics)
for for-profit and
non-profit providers

Increase hospital
efficiency; contain
health spending;
reduce length of stay

ICD–9 coding system
1993
Adopted US DRG
system (USAID
project)
1999 Hungarian-specific
system
2005 Adds reimbursement
for chemotherapy and
minor surgery
1994
Based on US model
Capitation Act
and related funding –
Italian version of
ICD–9–CM codes

Financing of hospitals
excluding investment
costs

Moderate
Change to DRGs was
phased in; idea
considered much
earlier than 2002;
stakeholders have
varying views
Easy–Moderate
International
literature scan, debate
and engagement of
stakeholders

Financial system to
Difficult
control growth of
1994–2002 choppy
hospital costs,
uptake, differences
increase accountability
among regions in
for production
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All hospital activity

Acute hospital care, ICF
for long-term chronic
care, same-day
treatment, ER care,
extended to chronic
hospital care

Inpatient hospital activity;
extends to nursing
homes

Table 16.1 (cont.)

Country

Japan

Portugal

Singapore

Year of adoption

2001
International scan and
study for a casemix
system
2003 Implemented for
payment using ICD–10
codes
1984
Feasibility study to
adapt US DRGs
(USAID project with
Yale)
1987 50% public hospitals
1990 90% public hospitals
1997 began assessing
international experience
1999 Casemix introduced
in public hospitals

Origin of system

Goals and purpose of
the system

Difficulty and duration
of adoption and
implementation

diffusion and use /
regional autonomy
Process oriented to
Moderate
Influenced by French
reflect medical practice; Incremental rollout;
and Australian systems
for regional health
hospital profiling and
strong IT system
improved efficiency
development, still
planning and Belgium
opposition from
and Britain for
physicians and
incremental develophospitals
ment
Easy
US DRG system
Rationalization of
Maryland cost-weight
resource allocation for But, at hospital level,
limited analytic use
system
inpatient care
Input from
production; hospital
Irish ICD–9 codes for
budgets; hospital
ambulatory surgery
comparisons; national
tariffs for inpatient and
ambulatory surgery
Australian National
Financing tool, expanded Easy
DRG V. 3.1
to cost efficiency and Engagement of
effectiveness
professionals, IT
support and pilot
coding training May
1998; full
implementation in
October 1998
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Extent of system use

Acute hospital care

Acute hospital care
including ambulatory
surgery in public
(NHS) hospitals

Public hospitals only;
covers acute care,
utilization management, benchmarking
for costs of inpatient
stay

Acute inpatient hospital
Moderate
50% of all inpatient care is care, excluding
psychiatry; 2005
reimbursed under the
version adds mental
NORD DRG system;
health and day surgery
administered by
services
counties, 2 do not use
DRG system; tiers of
use, varies by location,
size, type of service,
analysis tools
Acute somatic inpatient
Based on ICD–10 codes Contain costs by moving Difficult
Switzerland 1989–1990
care; attempts failed to
Software developed by
from per diem to
Federalist system, not
Study on
extend to outpatient
3M HIS
prospective payment;
supported by
the applicability of
benchmarking and
government; APDRG is treatment; exploring
DRGs to Swiss health
feasibility for
funding
a private group
care system
rehabilitation services
responsible for
1989 Association formed
developing and
to promote
implementing casemix
1997 APDRG (a private
and supporting IT
association) formed to
systems; variable
promote DRG use
uptake among the
2002 Funding of services
Cantons
in 2 cantons
2004 Swiss DRG group
formed to implement
national casemix based
funding
Sweden

Mid-1980s Benchmarking NORD DRG (Swedish
and cost analysis
version). Based on
1991 Payment system for
HCFA-DRGs, 1995
acute inpatient care in
version
3 counties

Increase hospital
productivity; support
policy goal of patient
free choice; funds
follow the patient
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Table 16.1 (cont.)

Country

Year of adoption

Origin of system

Goals and purpose of
the system

Initially based on US DRG Increase transparency,
United
1981–late 1980s
system, refined for UK
reward efficiency,
Kingdom
National Casemix
practice situation
support patient choice
Office
for service location and
1991 English version of
focus on quality
DRGs created
1991–1997 Health Care
Resource Groups
created HBGHealthcare Budget
Group, for primary
diagnoses
2003 Payment by Results
Length of Stay as a
Forecast hospital costs
United
1967
Government health care
States
Yale University research standard measure;
DRGs identified as the
budget control tool
project based on ICD
‘product of the
codes of 10,000
hospital’
diagnoses then
organized into 383
cases 1980–1982 72
hospitals in New Jersey
came under DRG
payment 1983
Congressional law
using DRGs as payment
for Medicare
beneficiaries

Difficulty and duration
of adoption and
implementation

Extent of system use

Acute inpatient,
1 April 2005
outpatient, emergency,
implementing Payment
adult critical care HRGs
by Results, a
for pediatrics, chronic
prospective, casemix
illness, specialized
payment system. 60%
services and cancer
of total NHS budget
(most ambitious in
terms of scope)

Inpatient care for
Moderate
Medicare beneficiaries
1980–1982 New Jersey
(government sponsored
hospitals
health insurance for
1983–1994 diffused to
individuals over 65
every region in the US
years or disabled)
1991–2000 states using
1992 prospective payment
DRG-based payment
system
systems
1997 extended to
outpatient, skilled
nursing, long-term
care, home care and
rehabilitation
Current APR-DRGs
development of refined
DRGs to capture severity
and risk of mortality
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features. Specifically, the use of any type of PCS requires key actors in a
health care system, especially hospital managers and clinicians, to change
their behavior. Perhaps more importantly, the use of a PCS requires changes
in interaction between actors both inside organizations (between hospital
managers and physicians) and across organizational boundaries (public
authorities, insurers, providers, professional organizations, and others).
Even for technical innovations, such as a CAT scanner, social factors
matter a great deal (Barley 1986). Clearly, technical characteristics are the
main drivers for technical innovation at the beginning of their diffusion, but
if innovations do not fit with the social context in which they are supposed
to diffuse, or if innovators are not able to convince social actors that the
innovation may serve their interests, diffusion is not likely to occur.
Managerial innovations are thus relatively sensitive to the social context
into which they are introduced, especially the power structure among
actors. This is all the more true for PCS, which were introduced in health
care systems with the aim of changing behavior. We discuss in detail below
how social contexts seem to influence PCS diffusion.
Technical features of PCS
The main technical components of PCS consist of statistical methods and
analyses that produce classification systems. Several distinctive features of
PCS as a technology seem to promote its diffusion.
First, the relevance of DRGs for particular countries can be assessed
empirically. Researchers and clinicians in any nation that considered using
DRGs could gather data to determine the extent to which the classifications
fit their circumstances. Such assessments could be used to counter critics
who claimed that their patients and medical care differed from those
of the US. Similarly, the ability to assess the fit of DRGs to local conditions empirically could counter a common and natural reaction to a new
technology: ‘‘if it wasn’t made here, it can’t work here.’’
Empirical support for this argument seems very strong. Several nations
(Australia, Hungary, Italy, Portugal, the UK, Canada) experimented with
the US-developed DRGs and made adaptations to them as a result. Sweden,
Denmark, and Norway worked together to develop a PCS for their region.
Another important feature of PCS to consider is that both the original
technology for producing DRGs, including the computer-based ‘‘grouper,’’
and revisions to the original, were available at reasonably low cost
(Kimberly 1993). Of course, innovations that require less initial investment,
and relatively little additional cost to revise, are more likely to be adopted.
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Moreover, the developers provided consultation and technical assistance
to potential users. Kimberly (1993) noted that Fetter and Thompson created
a group of researchers and analysts at Yale University to provide a variety of
services under contract. Under these contracts, potential users could receive
help to assess: the feasibility of assigning DRG codes to patient data; hospital
readiness to use such codes; and using the DRG-based cost and budgeting
model for hospital payment. As one would expect, countries that worked
closely with the Yale group were more likely to adopt the DRG approach
(Norway, Portugal, France, Sweden, and England).
The ability to assess the fit of DRGs empirically is closely related to another of
the system’s key characteristics: DRGs are flexible and, provided one can collect
and analyze the necessary data, they are easy to modify. Indeed, Fetter and
Thompson (1980; 1991) developed the US-DRGs in 1984 and revised them in
1987. The fact that DRGs are relatively easy to modify also contributes to their
acceptance, because advocates can use even minor changes strategically to
‘‘demonstrate’’ that a system has local relevance (e.g. as was the case in Japan).
More generally, the ability to adapt and refine DRGs reminds us that, in
some important respects, they are as much an idea or set of principles as
they are a technology, at least in the traditional sense of the term. They are
also malleable enough to serve the interests of a variety of potential users.
Indeed, the variation in their use described in the various country chapters
makes this point quite clear.
As Kimberly (1993) observed, analysis of the adoption and diffusion of
DRGs reveals the limitations of classic diffusion models. These models
assume that innovations are relatively static in their form and substance and
similar in their use from place to place (e.g. a CAT scanner). In the case of
PCS, however, the innovation itself has changed and continues to change
over time. The US, for example, continues to witness revisions to its system
twenty years after its initial adoption.
Moreover, the use of PCS varies greatly from one nation to another. In
particular, PCS has been used for health care planning, hospital management,
utilization review, and payment. For example, Canada uses its PCS extensively for a wide variety of patient services (inpatient, acute care, ambulatory,
chronic care), to pay providers, and monitor their use of resources. In contrast, in other nations, PCS are used in some locations (e.g. in one state) but
not nationwide and they are used only to monitor the use of resources in
hospitals. This variability suggests that a hallmark of PCS as a technology is
that it can both be refined and used for a variety of purposes. In sum, the
flexibility of the tool facilitates its adoption, but also its variability of use.
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Finally, as we saw in Chapter 1, DRGs had been adopted as part of the
prospective payment system in the US. This fact created interest in other
countries and provided evidence that a new approach to controlling the cost
of health care was feasible. Combined with the ability to adapt DRGs to
local circumstances, their empirical foundation, their relatively low cost,
and the availability of technical support for their use, the experience in the
US was the principal driver of their spread to other countries.

Characterizing the migration of PCS
To understand why PCS have diffused to many nations, it is useful to
characterize the variation in PCS and the processes that mark their adoption
both across and within nations. Specifically, we examine a nation’s adoption
and implementation of PCS along two dimensions: the extent to which a PCS is
used for: (1) multiple purposes, including as a payment mechanism and tool
for monitoring resource use; and (2) multiple categories of patients and services (acute care, chronic care, ambulatory care).
Variation in PCS purposes and use for patients
As noted above, PCS vary importantly in their goals and purposes. The most
ambitious goals are to use a PCS for both planning and paying an entire
nationwide system of health care providers. Examples of countries with these
goals are the US, Hungary, and Portugal; the UK, France, and Germany intend
to join this group. In contrast, other nations have not made efforts to implement their PCS nationally (i.e. PCS use is at a local, regional, and hospital
level). Examples of these countries include Australia and Sweden. Further,
some nations use PCS for planning and cost containment, but not for paying
hospitals or other providers; these nations include Singapore and Belgium.
Nations also vary in the extent to which they use classification systems
for patients in various segments of their health care systems. All nations
that we examined use their systems to classify patients in acute care
hospitals, and almost all nations use PCS for patients in both public and
private sector hospitals (exceptions include Portugal and Singapore whose
PCS covers only public hospitals). Fewer nations, but still the majority,
have extended PCS use to patients in non-acute care settings, including
ambulatory care, emergency care, chronic and nursing home care, and
psychiatric care.
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Duration and difficulty of PCS adoption
Even among nations that now use PCS extensively, there has been variation in
the duration and difficulty of PCS adoption and implementation. At one end of
this continuum are nations such as Hungary, Singapore, Portugal, Australia,
and Japan, where adoption and implementation proceeded relatively smoothly,
though in some instances, such as Australia, it is important to note that PCS is
not used nationwide to fund the provision of services. At the other end are
nations where implementation took years to achieve (e.g. the US, France). Even
some relatively small countries, as measured by GDP or population size, such as
Belgium and Switzerland, have experienced long trial periods with PCS.
Timing of adoption
The earliest widespread use of PCS occurred, of course, in the US, while the
most recent widespread use is in the largest economies of Europe: Germany,
France, and the UK. Other early adopters include Belgium, Canada, Portugal, Australia, Denmark, and Sweden, though, as noted above, the use of
PCS in the latter three countries remains limited.
Indeed, rather than consider the latter countries early ‘‘adopters’’ of PCS, it
might be more accurate and useful to note that they were among the first to
consider the use of PCS and analyzed and experimented with different versions
of them. Among this group are Denmark, France, Sweden, Switzerland, and
the UK (the latter, for example, established a National Casemix Office as early
as 1981). In other words, we can identify this group both as early experimenters
with the ideas of PCS, but also as late implementers of fully developed patient
classification systems: for many years, these nations used PCS on a limited basis
in terms of their purpose, geographic coverage, and the types of patients that
they classified. We conclude that the fact that some countries (e.g. Switzerland,
Australia, Sweden, Italy) have been involved in extensive trial periods both
highlights the flexibility of PCS, and helps to explain their attractiveness.

Accounting for variation in the adoption of PCS
Overview
Most analyses of the adoption and diffusion of innovations begin with the
now-classic S-curve model (Rogers 2003). In its most basic form, the
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S-curve model has two major components: an early stage in which initial
users adopt the new product, service, or technique, and a later stage in
which potential adopters become converts to an innovation. The form of
the S-curve, with time on one axis and the number of adopters on the
other, reflects the fact that typically, relatively few members of a social
system adopt an innovation when it is first introduced, and that over time,
the rate of adoption generally increases until the number of potential
adopters decreases and the rate slows down again (Guler et al. 2002).
The point at which an innovation moves from initial and early adoption
to reach larger numbers of potential adopters marks the inflection point in
an S-curve. Early adopters are seen as innovators, while later adopters are
seen as imitators, influenced by the behavior of their early-adopting
counterparts.
Dynamics of the S-curve of diffusion
In the past two decades, researchers using institutional theory have elaborated on the innovation and imitation phases of the S-curve (Scott 2001).
Institutional theorists argue that social systems and organizations typically
resist changes in their practices, in part because the value of these practices
is taken for granted. At the same time, social systems and organizations also
resist change for political and material reasons: actors who gain power and
resources from status-quo arrangements are reluctant to give them up.
This means that organizational practices that are in place and that are
consistent with widely-held views are highly resistant to change. Such
practices are, to a large extent, institutionalized. In turn, proposed innovations, such as PCS, might not only disrupt current practices, they are often
viewed as inappropriate, illegitimate, and even ‘‘unthinkable.’’
Nonetheless, practical needs drive organizations to seek innovations (Greve
2003). When their current practices prove to be inadequate for the work and
resources at hand, pioneering organizations search for and adopt (or invent)
new practices (Leblebici et al. 1991). Further, there is often a group of later
adopters of innovations who, though they initially resist change in practices,
face external social pressure to use practices that other organizations in their
field are increasingly using (Abrahamson 1991).
In other words, once some organizations adopt new practices, other
organizations slowly but surely come to view these innovations as necessary.
Indeed, social pressure to adopt new practices often increases with time, and
such pressure may result in innovations even in organizations that do not
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need them for technical reasons (Fligstein 1991). These social pressures
drive the imitation phase of the diffusion of innovations. In addition,
pioneers may derive real economic benefits from the new practices they
have adopted, benefits that become visible externally and that influence
others to adopt as well.
In sum, these arguments suggest that nations’ use of PCS/DRG systems
was driven, on the one hand, by local concerns about managing resources
and health care providers and, on the other hand, by social pressures that
were both internal and external to health care systems. We examine these
issues in more depth below.
Rogers’ model
In addition to analysing PCS diffusion from an institutional perspective, we
also draw on the work of Rogers (2003). Based on extensive reviews and
analyses of the innovation literature, Rogers developed a simple, yet powerful,
framework, which argues that both the innovation stage and imitation stage
of the S-curve pattern are driven by characteristics of the innovation itself
(e.g. can the innovation be modified to fit local circumstances?), characteristics
of the potential adopter or adopting system (e.g. how strong is the technical
infrastructure related to the innovation?), and interaction between the two.
Building on our discussion above about important technical and social
aspects of PCS as an innovation, we organize the discussion below around
two sets of key factors: (1) characteristics of the adopting system (i.e. the
national context for PCS adoption and use); (2) interaction between
adopting systems and the innovation that is driven by individuals who acted
as carriers of ideas and champions for PCS, networks of PCS users, and
other key constituents.

National context: The role of economic, political, social and
technical forces
Context may matter a great deal in the extent to which innovations, ranging
from new consumer goods (e.g. Tellis and Stremersch 2003), to management practices (e.g. Guler, Guillen and MacPherson 2002), and marketoriented political reforms (Henisz, Zelner and Guillen 2005), are adopted
and implemented. We argue that key economic, political, and social factors
matter specifically in the case of PCS.

Cambridge Books Online © Cambridge University Press, 2010

359

Conclusions: The global diffusion of casemix

Economic and performance pressures
At base, PCS are concerned with accounting for resource allocation and
consumption in the health sector. In nations that are not so concerned with the
performance of their health systems, including its costs, or the value that such
systems are delivering relative to costs, one would expect less emphasis on
accounting for resource allocation, cost control, or planning for expenditures,
and, hence, less interest in using PCS.
Of course, one could argue that most nations in the world have been
highly concerned with controlling costs in the health sector and, as a result,
have some motivation to at least consider the use of PCS to achieve fiscal
control. Thus, a key question is the extent to which decision makers perceive PCS as useful for cost containment: the more this is the case, the more
likely it is that a nation will attempt to implement PCS.
Nonetheless, though most nations are concerned with the performance of
their health care systems, we argue that fiscal concerns vary from one nation to
another, both in their intensity and timing. England provides an example of
this argument, as until quite recently, England spent less on health care than
almost any other developed Western nation. In this context, it was difficult to
make the case that PCS was an important managerial tool to help control costs,
at least on a relative basis. As a result, it is only now that England’s PCS will be
used in combination with prospective payment as a means to control the use of
resources.
Similarly, we expect less pressure to adopt PCS in countries that are
experiencing economic stability, growth, or periods of economic well-being.
Further, in nations that do adopt PCS in such economic periods, we expect the
use of such systems to be relatively limited and driven by social, as opposed to
economic, pressures. Sweden and Denmark fit this argument, and though they
experimented relatively early with PCS, their implementation has lagged
behind other nations.
In contrast, we expect nations that are experiencing a general economic
downturn or an increase in health care expenditure, particularly increases
that affect general business performance, to be more likely to adopt PCS,
and to do so more quickly and extensively. The early development and
use of PCS in the US is a good example. The implementation of the DRG
system was driven by rising health care costs, which affected employers
who pay for employees’ health insurance. Employers had to pass on
these rising costs to consumers in the form of the prices they charged for
goods and services (e.g. the US auto industry) and, in the early 1980s,
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the US experienced a financial recession that fuelled the motivation
for DRGs.
It is important to note, however, that, in practice, PCS that involve a
prospective payment scheme (such as in the US) may improve hospitals’
efficiency, but PCS, even combined with prospective payments, do not seem
to contain costs, unless other changes are made to limit the volume of services
provided (e.g. as in Italy, Hungary, and Denmark). In other words, under
PCS with prospective payment, hospitals have a direct incentive to increase
the volume of services they provide, and unless the productivity gains due to
PCS balance volume increases, total national expenditure increases.
Technical context
Kimberly (1993) noted, and we agree, that PCS require considerable investment in information systems, computing capacity and technical expertise.
More generally, a relatively complex managerial innovation, such as PCS, is
more likely to be embraced to the extent that there are other managerial
systems in place to support it. Perhaps the most important of such systems
are computerized – electronic information systems. It appears that the relatively smooth implementation of PCS in Hungary, Japan, and Singapore
occurred in part due to the strength of related technical systems, some of
which had been in development for many years before PCS was considered.
In Hungary, for example, the Ministry of Health had been gathering and
evaluating data from samples of inpatient care cases since 1974.
Political agendas
An important aspect of political context concerns national political agendas,
as expressed by ruling governments and political parties. The role of political
agendas, especially agendas for health care, is obvious, but nonetheless it is
important to consider them (Kingdon 1984). When improving the performance of the health system has been a political priority, the adoption and
implementation of PCS have moved more quickly and smoothly. Examples
include Portugal, whose PCS was implemented fairly easily between 1987 and
1990, and Singapore, which implemented its system between 1997 and 1998.
The structure of national political and health care systems
We focus here on the structure of national political and health care systems,
more specifically, on the structure of decision making that governs these
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systems. To what extent are decisions that affect the ‘‘rules of the game,’’ and
the allocation of resources, centralized vs. decentralized, and how many different actors are involved in such decisions (Meyer, Scott and Strang 1987)?
In decentralized and fragmented political systems, many actors have the
potential to influence critical decisions, making the resource allocation
process contentious and hence both slower and potentially less uniform
across political sub-units. In centralized and more unitary systems, the
resource allocation process can unfold more quickly; once a decision is
made to move ahead in a particular domain, resources can be allocated
relatively quickly and uniformly across the entire system. The same arguments are true for the structure of decision making in a nation’s health care
system. More fragmented health care systems have both a greater number
of, and more varied, actors whose interests need to be taken into account
(e.g. public and private payers and service providers).
It is important to note that centralization in political systems does not
always imply centralization and lack of fragmentation in health care systems. Though it has a relatively centralized political system, France, for
example, has a relatively fragmented health care system. The system includes
a mix of both public and private health care providers, and sickness funds
that are independent from the national state (i.e. a Bismarck system). In
contrast, England, which like France has a centralized political system, also
has a centralized, relatively unitary health care system (i.e. a Beveridge
system). The English health care system is characterized by relatively hierarchical decision making, with services that are paid for primarily by
national tax revenues and provided mainly by a large public bureaucracy,
the National Health Service.
In general, we argue that nations with more fragmented political and
health care systems will have more difficulty in adopting PCS, simply because
such systems have more actors and these actors are more heterogeneous.
Further, not only will fragmentation slow the process of PCS diffusion, but it
should also be related to more variation in the uses for PCS because different
actors are more likely to see different uses for PCS.
In Italy, Switzerland, Denmark, Germany, and Sweden, nations with a
federalist form of government and relatively decentralized and fragmented
decision making, the structure of government decision making slowed the
adoption of PCS (Ring, Bigley, Khanna and D’Aunno 2005). Germany, for
example, has strong political decentralization, and though it has a universal
health insurance system, it also has many sickness (insurance) funds. There
is also a mix of public and private service providers, with weak integration
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between hospital care and primary care. This combination of characteristics
creates a relatively fragmented system for both politics and health care and, as
Kimberly and de Pouvourville (1993) argued, the PCS concept failed to diffuse
in Germany because there were too many people to convince to promote its
diffusion. It was 2005 before the German federal government was able to
impose a policy for PCS and health care cost control at a national level.
Similarly, though Switzerland is a smaller country, it mirrors Germany’s
structure in politics and health care, and although there was early experimentation with PCS, it diffused only in a few areas (Geneva and Lausanne)
where hospital managers wanted to use it for utilization review. In contrast,
we observe that in Singapore, Portugal, and Japan, countries that have more
unitary and centralized systems, once a decision was made to adopt PCS,
the result was a national roll-out in a relatively short period of time.
It is important to note, however, that decentralization in national governance may mean strong centralization at regional levels (provinces in
Canada are a good example). Thus, there could be rapid diffusion of PCS
within local centralized governments that support the concept of PCS. In
fact, national political agendas for health care are often so overcrowded with
reforms (e.g. concerning public health and primary care) that it is quite
difficult to maintain an emphasis on one reform versus another. This
problem is particularly evident in national governments that are centralized,
whereas at the regional level, governments may have more capacity to set
agendas that focus on PCS.
Finally, the size of a nation and its health care system may be another
structural characteristic that explains differences in the speed of PCS diffusion. To the extent that other contextual factors (i.e. performance pressures; political agendas; centralized decision making) are supportive, PCS
diffusion may be more likely to occur more rapidly in smaller countries (e.g.
Portugal, Singapore, and Hungary).

Context and innovation interact: The roles of social actors
Though national context and characteristics of the initial innovation (the
US-DRG system) influenced PCS adoption and use, individuals and social
networks have also played, and continue to play, a central role. As we look
across the experience of the fifteen countries included here, we see three sets
of actors as being particularly influential: (1) individuals who were carriers
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of, and champions for, the innovation; (2) networks of users, including
those who developed a PCS research industry; and (3) major stakeholders at
the local level in health care systems, especially physicians and regional and
local hospital managers.
The roles of carriers and champions
We distinguish here between individuals who play two types of roles: those
who carry to their nations the ideas, concepts and principles of patient
classification analysis (often researchers linked to universities or public
agencies) versus individuals who are champions for change and promote the
use of PCS. Carriers of ideas are similar to the so-called ‘‘boundary spanners’’
or ‘‘cosmopolitans’’ identified in prior research on the diffusion of innovation
(Kimberly 1981): these individuals are likely to travel across national
boundaries and are connected via social networks and communication
channels (e.g. professional journals) to varied sources of information.
Champions, on the other hand, are individuals who, for a variety of reasons,
are deeply committed to an innovation and who are willing to invest significant
amounts of their time and resources to implement it. Their principal challenge
is resistance to change, a universal phenomenon found in all social systems.
Some individuals such as George Palmer in Australia, Jean de Kervasdoué in
France, and Jean Blanpain in Belgium played the roles of both carrier and
champion.
Both carriers and champions are important. Carriers focus more on communicating about, and studying various aspects of, PCS; champions are
needed because they focus more on action than ideas. To illustrate, consider
the case of Switzerland. Here we see that there was an active group of carriers
who conducted studies of patient classification systems in the mid to late
1980s. But the absence of real champions for change in the political system
has undoubtedly contributed to Switzerland’s relatively slow adoption of PCS.
The importance of individuals, or small groups of individuals, playing
both these roles should be obvious from the preceding chapters but, at the
same time, they should not be overlooked. Some of these carriers and
champions were linked directly to Fetter, Thompson, and the Yale group.
For example, George Palmer, whom we consider both a carrier and
champion, played a pivotal role in DRG development in Australia, and from
1970 to 1987 he periodically travelled to the US and worked with the Yale
group. Similarly, Jean de Kervasdoué came into contact with the Yale group
in the late 1970s and subsequently used his position as Directeur des
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Hopitaux in the Ministry of Health in France to motivate experimentation
with a system based on DRGs.
Another observation is that champions who were not closely linked to
decision makers within health care systems were not as effective as champions
who were somehow part of those systems. In other words, implementation of
PCS was facilitated by champions who occupied positions of authority in their
health care systems that gave them the power to allocate critical resources.
Though decision-making authority is never absolute, individuals who are both
champions and decision makers face fewer obstacles to implementing PCS
than others. The case of Singapore illustrates this point: the Ministry of Health
was both a carrier and a champion, and held decision-making power, and PCS
was implemented relatively quickly. In sum, carriers and champions heavily
define the path by which an innovation enters a social system. Variation in who
plays these roles, and how well they play them, affects PCS adoption and
implementation.
Within institutional theory, an important new literature has emerged on
carriers and champions for change (e.g. Scott et al. 2000). This literature
describes and analyzes individuals who lead change in systems that are
highly institutionalized, such as national health systems (Battilana 2006).
Battilana and her colleagues reviewed forty recent papers that examined the
role of what they term ‘‘institutional entrepreneurs’’ (ie. individuals who
attempt to change organizations and practices that are so widely accepted
that they are taken for granted (see also Fligstein 1997).
One conclusion from this review, and from Battilana’s (2006) study of
leadership and change in England’s NHS, is that institutional entrepreneurs
are not necessarily ‘‘insiders’’ who hold formal positions of authority.
Rather, challenges to the status quo often come from those individuals and
organizations that are outsiders; they are relatively less powerful and occupy
positions at the periphery of organizational networks (Leblebici et al. 1991).
How well does this conclusion fit our arguments and the data for PCS
carriers and champions? Evidence from the chapters here suggests a good fit
insofar as, in many cases, the individuals who brought the ideas, concepts and
principles of PCS to their nations (carriers) often were not insiders in government or national health systems, but rather researchers and academics. As
outsiders, they had the advantage of being able to see the strengths of PCS. At
the same time, however, as outsiders they did not necessarily have the
authority or power to be effective champions with the ability to implement
changes such as PCS. This may help to explain why many nations have
experimented with PCS, but not implemented them as fully as possible.
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Networks of users
Recent research indicates that networks, such as those we discuss here, have
promoted the worldwide diffusion of a wide range of innovations, including
economic policies (Henisz, Zelner and Guillen 2005), organizational practices
(Guler, Guillen and MacPherson 2002), and educational systems (Schofer and
Meyer 2005). We first discuss the development of PCS user networks and
then examine their effects on PCS diffusion.
In his analysis of the migration of DRGs to Western Europe, Kimberly
(1993) identified a series of programs, conferences, and events that developed
networks of PCS users. These initiatives ranged from an annual one-week
educational program begun at Yale in 1978 to promote the use of DRGs, to
the formation of an association of Patient Classification Systems in Europe in
1985. In addition, Kimberly (1993) noted that a modest, though significant,
DRG-focused research industry has developed whose purpose is to evaluate
various aspects of DRG use and implementation. As a result, research on
DRGs has produced a set of individuals with particular skills and interests in
the analysis of PCS.
The networks that grew from these various initiatives and research programs now span national boundaries and involve multiple stakeholders.
In fact, the Association of Patient Classification Systems recently held its
22nd annual conference, with 270 individuals attending from thirty-four
countries.
These networks appear to have had several beneficial effects on the
adoption of PCS. One is that they facilitate information-sharing about
technical issues and problems that PCS pose. Perhaps more important than
the technical information within the networks, is the sense of community
that they generate. In other words, these networks create both social
structures (such as the PCS Association) and a shared world view. From this
cohesion comes the legitimacy and support that are needed to promote PCS
in the face of obstacles to their adoption and implementation. Finally, as
these networks have increased in size and prominence, they also have created a sense of momentum, suggesting that PCS are the way of the future
and a necessary management tool for modern health care systems.
Major stakeholders
In addition to the role of individuals who influence or make policy decisions within health care systems, three other groups of actors must be
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considered: physicians, hospital managers, and to some, though a lesser
extent, regional health system managers, who are particularly important
in nations that have decentralized public health care systems (such as
Italy, Sweden, and Denmark). Of these actors, physicians are typically the
most powerful and they hold particular power when it comes to implementing PCS. Though they may not be able to resist policy makers’ plans
to adopt a PCS, physicians can make it very difficult to implement one
smoothly.
In Belgium, for example, physicians expressed strong opposition to PCS
on the basis of concerns about losing their autonomy and practising
medicine with a focus on money rather than quality of care. Motivated by
these concerns, physicians were apparently able to slow down the implementation of the system until recently. This is despite the fact that Fetter
spent a sabbatical year in Belgium in the late 1970s and the Ministry of
Health supported relatively extensive research on PCS. In general, the evidence supports the view that the more involved physicians are in the
development of a PCS from its inception, the more likely they are to accept
its use. Japan and Hungary provide good examples of this.
Further, it may be the case that involving physicians adequately means
that a PCS must be developed or at least modified to fit, or at least appear to
fit, local circumstances. A clear trade-off is that when local physicians are
involved in developing or modifying a system, it takes longer to develop or
modify. But there also is likely to be a significant decrease in the time that it
takes for the system to be used.
Of course, it is inaccurate to consider that PCS pose only threats to
physicians’ interests and that they will universally see them as such. The
Hungarian experience seems to indicate that physicians, like other stakeholders in Hungary, viewed a patient classification system as a better way to
allocate scarce resources and, as a result, they supported, and actively
participated in PCS development and implementation.
Though physicians typically hold more power than hospital and regional
health system managers, these latter two groups matter as well. Their
support for PCS seems to be mixed. On the one hand, PCS increases
managers’ uncertainty in the short run. This is especially true to the extent
that hospital payment has been linked to a PCS (as in the US). In these
cases, managers have been uncertain about how PCS would affect hospital
financial performance and, importantly, their relationships with physicians.
To what extent would the implementation of a PCS drive a wedge between
hospital managers and physicians?
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Further, PCS clearly puts more responsibility on managers to be
accountable for hospital performance. In the US, for example, hospital
managers did not initially embrace DRGs and their introduction compelled
managers to significantly improve their skills in cost accounting, and
financial analysis and planning (Gapenski 1999). Duckett’s chapter on
Australia also emphasizes the changes in managers’ skills that were necessary
with the introduction of DRGs.
On the other hand, PCS data give local and regional managers a tool to
improve planning and monitor resource use. Perhaps more importantly,
PCS data also give managers a foundation for efforts to change physician
behavior. Physicians often respond well to data-driven arguments about the
need for changes to improve their performance. PCS data provide managers
with information that they had previously lacked. Thus, despite managers’
short-term concerns about the introduction of PCS, managers’ interests
often align well with their use and in many nations, though managers were
not cited as early advocates of PCS, they have rarely been cited as vocal
opponents.
When PCS is introduced in nations that have decentralized health care
systems, it is important to consider regional managers. Their interests
appear to be similar to those of local hospital managers. Italy provides
perhaps the best example because it is divided into twenty-one regions and
each one is responsible for administering its own PCS. As Tedeschi notes
above, regional managers in Italy must balance a global health care budget
and DRGs enable them to plan for, and monitor, resource use. It should be
clear, however, that in Italy, as elsewhere, the ability to plan and monitor
resource use does not necessarily enable managers at any level to control
costs. Other examples of nations where regional, county or municipal
managers should be considered include Denmark and Sweden. Their
experience seems comparable to that of Italy.
Finally, though we have discussed the interests of major stakeholders
separately, it should be clear that it is more likely that a PCS will be adopted
and implemented (both in a timely manner and more fully) to the extent
that these actors share similar values and views about PCS. Hungary
probably provides the best example of such alignment; to a lesser extent, this
promoted DRG diffusion in Portugal (though in this case, DRGs were not
accompanied by a payment plan). It is well-known, however, that stakeholders in health care systems often hold different, rather than similar,
interests and this is yet another reason why we do not observe the typical Scurve of innovation adoption for DRGs/PCS.
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What does the future hold?
Given the uneven migration of DRGs/PCS around the globe, it is somewhat
risky to speculate about future developments. Nonetheless, two trends seem
likely. First, we expect to see the continued migration of PCS to nations
around the world. As noted above, representatives from thirty-four nations
recently attended the 22nd annual meeting of the Association of Patient
Classification Systems and this number has increased year on year. At the
same time, evidence from the chapters here suggests that this migration will
not proceed smoothly or in a simple S-curve fashion either within, or
across, nations.
Second, we expect to see continued evolution in DRGs/PCS themselves
and, more generally, in the use of classification techniques to analyze and
manage health care services. In particular, there have already been efforts to
extend the use of classification systems to patients and services that are nonhospital based in several nations (e.g. Canada). These efforts are likely to
increase as policy makers and managers seek ways to improve use of scarce
resources.
The Netherlands is considering perhaps the most innovative use of classification systems in health care. Rather than classifying medical conditions and
treatment, this approach classifies care episodes. For example, an episode of
care for an elderly diabetic individual might consist of transportation to and
from a primary care clinic for a routine physical exam. That is followed by a
nutrition consultation with a dietary specialist. In other words, this approach
classifies a bundle of related services, rather than using discrete medical conditions and treatments as the units of analysis. Focusing on such care episodes
provides a more comprehensive and accurate picture of resource use and, as a
result, this approach holds the potential to be very useful.
There are clearly challenges to such extensions of DRGs and they raise key
questions: are there limits to the use of classification systems? How well do
these systems deliver on the promises that advocates make for them? Of
course, to the extent that patients, services or care episodes vary considerably,
it is difficult to develop reliable classifications. In the case of psychiatric care,
for example, there is a great deal of variation in patient characteristics,
symptoms, etiology of problems, and treatment. Nonetheless, Canada and
Sweden are examples of nations that are now using classification systems for
psychiatric care and many other nations are working with similar extensions
for ambulatory (outpatient) care in general.
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Efforts to extend the use of classification approaches to focus on care
episodes underscore one of this chapter’s most important points: PCS is
better thought of as an idea or a set of principles rather than a technology in
the traditional sense of the term. Similarly, PCS is a malleable tool that has
been modified to fit local circumstances. These characteristics of PCS make
its migration difficult to analyze and predict. But, perhaps rather than
viewing DRGs narrowly as the innovation of interest, we should focus
attention more broadly on empirically-derived classifications of a wide
range of units of analysis, including events, activities, processes, patients,
medical conditions, and treatments.

Implications for policy makers, managers and researchers
Drawing on prior analyses of the diffusion of innovations in general (Rogers
2003) and DRGs in particular (Kimberly and de Pouvourville 1993), this
chapter proposed a three-part model to assess PCS adoption and implementation. We argued that key characteristics of national context, DRGs as
an innovation, and social interaction combine to account for patterns of
PCS migration and use around the world.
Several themes emerge from the analysis above. First, policy makers and
managers need to think carefully about the purpose of using PCS/DRGs.
National policy makers and regional and county managers, as well as local
hospital managers, are using these systems for a wide variety of purposes.
The more ambitious objectives, such as using a system to pay for acute
inpatient hospital care or even outpatient, ambulatory care, are difficult and
often take several years to achieve. Perhaps the most important distinction
is between using PCS to plan for and monitor resource use, versus using
PCS to pay for services. Given the difficulties of introducing PCS in a health
care system of any size, it appears that policy makers should give strong
consideration to using PCS as a planning tool initially, even if their ultimate
objective is to design a payment plan around their classification system.
Second, in only a minority of cases have nations adopted a system developed
externally without making at least minor changes to it. Using systems
developed in other nations is difficult due in part to the power of local-level
actors, especially physicians, who are likely to resist changes that originate
externally and are externally imposed. The major consideration here is the
extent to which a system needs to be developed locally and what role various
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stakeholders will play in development efforts. As noted above, one strength of
PCS is its malleability, and it may be wiser to draw on this strength rather than
focus on the efficiency of importing a system in its entirety.
Third, as in other cases of social and organizational change, implementation of this innovation takes more time and resources than anticipated;
politics are common. Many incremental changes are needed to fine-tune
systems over time and promote their use. In many nations (though not all)
there has been a game of ‘‘cat and mouse’’ played among government
agencies, policy makers, and health care providers. The latter want to use
PCS/DRG to promote accountability and efficient use of resources, while
the former are concerned about the fairness of payment systems and protecting their autonomy to use resources as they see fit for local patients and
communities. These conflicts seem inevitable, and should be taken into
account by implementation plans.
Fourth, this leads to a related observation: understanding the structure of
decision making and the pattern of relationships among actors in a health
care system will be critical for selecting approaches to implementation. In
nations with fragmented health sectors, the involvement of local actors will
be more than in nations that are less complex, and where decision making is
more unified or centralized. In such cases, top-down decision making and
implementation of PCS/DRGs are more likely to be successful.
Fifth, the availability of good data and effective information systems is
critical to the effective use of PCS/DRGs. Effectively innovating in this
management area depends at least in part on having relatively sophisticated
information systems in a nation’s health care sector. In other words, policy
makers and managers should take into account the technical conditions that
promote success in PCS adoption and use. This includes the technical
ability of local hospital and regional managers whose skills in accounting
and financial planning and analysis will be taxed by the implementation of
PCS, especially if it involves a payment plan.
Sixth, following the above points, successful innovation in this area seems to
require small-scale experiments and trial-and-error. There is a need for health
care systems to become learning systems. It is important for researchers and
policy makers to collaborate on studies that can inform policy and management decisions. Indeed, it would be very difficult to adopt a classification
system without strong contributions from researchers conducting empirical
studies to support PCS development and implementation. Studies of implementation, as opposed to work that focuses on the development of classification systems per se, are especially needed to support PCS use.
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Finally, in many cases we observe that an individual (or small group of
individuals) emerged as leaders to promote the adoption of PCS/DRGs.
Despite the importance of analysing the social context and structure of
nations and health care systems, there is still an important place for understanding the role of institutional entrepreneurs, champions, and social networks in the process of innovation. These are individuals who see the need for
changes in current systems and who are motivated to make them. It is
important to understand who these individuals are, and how they leverage
resources to promote the adoption of PCS/DRGs. Identifying champions for
change and linking them to established networks of PCS users is a critical first
step. The more that carriers of ideas are isolated from champions for change,
the longer it will take to adopt PCS in a country or region, and the less
smoothly implementation will proceed.
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